Stratification of Systemic Lupus Erythematosus Patients Into Three Groups of Disease Activity Progression According to Longitudinal Gene Expression
Arthritis & Rheumatology2018Vol. 70(12), pp. 2025–2035
Citations Over TimeTop 10% of 2018 papers
Daniel Toro‐Domínguez, Jordi Martorell‐Marugán, Daniel Goldman, Michelle Petri, Pedro Carmona‐Sáez, Marta E. Alarcón‐Riquelme
Abstract
Our findings indicate that SLE patients can be stratified into 3 subgroups of patients who show different mechanisms of disease progression and are clinically differentiated. Our results have important implications for treatment options, the design of clinical trials, our understanding of the etiology of the disease, and the prediction of severe glomerulonephritis.
Related Papers
- → Animal Models of Lupus and Lupus Nephritis(2015)44 cited
- → Lupus podocytopathy: a distinct entity of lupus nephritis(2017)43 cited
- → Gene Expression Profiling in the Skin Reveals Strong Similarities between Subacute and Chronic Cutaneous Lupus that Are Distinct from Lupus Nephritis(2021)34 cited
- → Neuraminidase activity mediates IL-6 production by activated lupus-prone mesangial cells(2018)25 cited
- Clinical and immunological analysis of extrarenal lupus activity in lupus nephritis patients after end stage renal disease(2003)